Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: Interaction with cigarette smoking

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 26-34

  Wei, Qi ^a   Doris, Peter A ^a   Pollizotto, Martin V ^a   Boerwinkle, Eric ^a,b   Jacobs Jr , David R ^c   Siscovick, David S ^d   Fornage, Myriam ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Calcium; EPHX2; Genetics; Smoking

Indexed keywords

EPOXIDE HYDROLASE;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; CORONARY ARTERIOSCLEROSIS; EPOXIDE HYDROLASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SOLUBILITY;

EID: 33845535114     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.021     Document Type: Article

References (57)

1. Yu Z., Xu F., Huse L.M., et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87 (2000) 992-998
2. Davis B.B., Thompson D.A., Howard L.L., et al. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 99 (2002) 2222-2227
3. Heizer M.L., McKinney J.S., and Ellis E.F. 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles. Stroke 22 (1991) 1389-1393
4. Imig J.D., Navar L.G., Roman R.J., Reddy K.K., and Falck J.R. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7 (1996) 2364-2370
5. McGiff J.C., and Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 10 (2001) 231-237
6. Munzenmaier D.H., and Harder D.R. Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release. Am J Physiol Heart Circ Physiol 278 (2000) H1163-H1167
7. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285 (1999) 1276-1279
8. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82 (2002) 131-185
9. Capdevila J.H., Falck J.R., and Estabrook R.W. Cytochrome P450 and the arachidonate cascade. FASEB J 6 (1992) 731-736
10. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 (1999) 493-497
11. Fisslthaler B., Hinsch N., Chataigneau T., et al. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 36 (2000) 270-275
12. Quilley J., and McGiff J.C. Is EDHF an epoxyeicosatrienoic acid?. Trends Pharmacol Sci 21 (2000) 121-124
13. Campbell W.B., Falck J.R., and Gauthier K. Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor in bovine coronary arteries. Med Sci Monit 7 (2001) 578-584
14. Campbell W.B. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 21 (2000) 125-127
15. Sun J., Sui X., Bradbury J.A., et al. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90 (2002) 1020-1027
16. Yang B., Graham L., Dikalov S., et al. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60 (2001) 310-320
17. Blankenhorn D.H. Coronary artery calcification: a review. Am J Med Sci 42 (1961) 1-49
18. McNamara J.J., Molot M.A., Stremple J.F., and Cutting R.T. Coronary artery disease in combat casualties in Vietnam. JAMA 216 (1971) 1185-1187
19. Przybyla-Zawislak B.D., Srivastava P.K., Vazquez-Matias J., et al. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64 (2003) 482-490
20. Sandberg M., Hassett C., Adman E.T., Meijer J., and Omiecinski C.J. Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275 (2000) 28873-28881
21. Srivastava P.K., Sharma V.K., Kalonia D.S., and Grant D.F. Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure. Arch Biochem Biophys 427 (2004) 164-169
22. Fornage M., Boerwinkle E., Doris P.A., et al. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the coronary artery risk development in young adults (CARDIA) study. Circulation 109 (2004) 335-339
23. Clark A.G. The role of haplotypes in candidate gene studies. Genet Epidemiol 27 (2004) 321-333
24. Schaid D.J. Evaluating associations of haplotypes with traits. Genet Epidemiol 27 (2004) 348-364
25. Maresh J.G., Xu H., Jiang N., Gairola C.G., and Shohet R.V. Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol Genomics 21 (2005) 308-313
26. Friedman G.D., Cutter G.R., Donahue R.P., et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41 (1988) 1105-1116
27. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of multi-ethnic study of atherosclerosis (MESA) and coronary artery risk development in young adults (CARDIA) study. Radiology 234 (2005) 35-43
28. Hinds D.A., Stuve L.L., Nilsen G.B., et al. Whole-genome patterns of common DNA variation in three human populations. Science 307 (2005) 1072-1079
29. Carlson C.S., Eberle M.A., Rieder M.J., et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 (2004) 106-120
30. Fornage M., and Doris P.A. Single-nucleotide polymorphism genotyping. In: Fennell J.P., and Baker A.H. (Eds). Hypertension-methods and protocols (2005), Humana Press, Totowa, NJ 159-172
31. Reich D.E., Cargill M., Bolk S., et al. Linkage disequilibrium in the human genome. Nature 411 (2001) 199-204
32. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
33. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
34. Comeron J.M., Kreitman M., and De La Vega F.M. On the power to detect SNP/phenotype association in candidate quantitative trait loci genomic regions: a simulation study. Pac Symp Biocomput (2003) 478-489
35. Shifman S., Kuypers J., Kokoris M., Yakir B., and Darvasi A. Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 12 (2003) 771-776
36. Fornage M., Lee C.R., Doris P.A., et al. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke. Hum Mol Genet (2005)
37. Beckman J.A., Ganz J., Creager M.A., Ganz P., and Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 21 (2001) 1618-1622
38. Hunt J.L., Fairman R., Mitchell M.E., et al. 3rd. Bone formation in carotid plaques: a clinicopathological study. Stroke 33 (2002) 1214-1219
39. Nandalur K.R., Baskurt E., Hagspiel K.D., Phillips C.D., and Kramer C.M. Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol 184 (2005) 295-298
40. Shaalan W.E., Cheng H., Gewertz B., et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg 40 (2004) 262-269
41. Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31 (2003) 3568-3571
42. Gaedigk A., Leeder J.S., and Grant D.M. Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase. DNA Cell Biol 16 (1997) 1257-1266
43. Jendraschak E., Kaminski W.E., Kiefl R., and von Schacky C. The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. Biochem J 314 Pt 3 (1996) 733-737
44. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 (2004) 1731-1737
45. Tang W., Detrano R.C., Brezden O.S., et al. Racial differences in coronary calcium prevalence among high-risk adults. Am J Cardiol 75 (1995) 1088-1091
46. Doherty T.M., Tang W., and Detrano R.C. Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. J Am Coll Cardiol 34 (1999) 787-794
47. Newman A.B., Naydeck B.L., Whittle J., et al. Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol 22 (2002) 424-430
48. Lee T.C., O'Malley P.G., Feuerstein I., and Taylor A.J. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. J Am Coll Cardiol 41 (2003) 39-44
49. Bild D.E., Detrano R., Peterson D., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111 (2005) 1313-1320
50. Spiecker M., Darius H., Hankeln T., et al. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 110 (2004) 2132-2136
51. Cohen J.C., Kiss R.S., Pertsemlidis A., et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
52. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 (2001) 502-510
53. Wright A.F., and Hastie N.D. Complex genetic diseases: controversy over the Croesus code. Genome Biol 2 (2001) 1-8
54. Cargill M., Altshuler D., Ireland J., et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22 (1999) 231-238
55. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 21 (1999) 56-60
56. Sham P.C., Zhao J.H., and Curtis D. The effect of marker characteristics on the power to detect linkage disequilibrium due to single or multiple ancestral mutations. Ann Hum Genet 64 (2000) 161-169
57. Schmelzer K.R., Kubala L., Newman J.W., et al. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102 (2005) 9772-9777